SLIDE 4 4
- Appropriate treatment
- Quality of evidence: Good
- Clinically significant short-term pain relief
- Consider other options for longer duration pain relief
Intraarticular corticosteroid for knee OA: Osteoarthritis Research Society International 2014
McAlindon TE et al. OARSI Guidelines for the Non-Surgical Management of Knee Osteoarthritis. Osteoarthritis and Cartilage 2014.
- 2-year RCT
- Patients with knee OA (mild-moderate)
- Q3 month triamcinolone or saline knee injection under
ultrasound x 2 years
- Annual knee MRI, WOMAC q 3 months
- 140 randomized patients
- Mean age 58 years
- 54% women
- Significantly more cartilage loss in triamcinolone
group compared to saline group
- No significant difference in pain between groups at
2 years
Risks of steroid injection in the knee
- Diabetics: increased blood sugar, 300 mg/dl starting as early as 2 hours after,
lasting 5 days (controversial)
- Facial flushing: 10% with Kenalog
- 19-36 hours post-injection
- Skin or fat atrophy
- Post-injection steroid flare: 1-10%
- Synovitis in response to injected crystals
- Within hours - 48 hours post-injection
- More common in soft tissue injections (20% of trigger points) than intra-
articular injections
- Septic arthritis: 1/3000-1/50,000
- 1-2 days after injection
Habib GS. Clin Rheumatol, 2009. UpToDate, “Joint aspiration or injection in adults,” 2010.